Industry: Pharmaceuticals, Biotechnology
TissueGene is developing novel therapeutic technologies to reduce the long-term, escalating pain and suffering associated with degenerative disorders. To investigate the etiology of diseases in the Post-Genomic Era, TissueGene is engaged in research spanning the fields of clinical medicine and molecular biology. In addition to the elucidation of novel therapeutics, TissueGene is also actively engaged in discovering methods to improve the wellbeing of individuals. ( www.tissuegene.com )
TissueGene , Inc
209 Perry Parkway Suite 13
Gaithersburg, Maryland 20877
USA
Tel: (301) 921-6002
Fax: (301) 921-6011